Two VCs from Merck Global Health Innovation Fund recently offered fundraising advice for digital health companies. They told these firms to expect slower funding timelines, urged them not to be afraid of down or flat rounds, and advised them to spend time nailing down the specifics of their growth narrative.
The conference highlights the convergence of digital health and drug development. Among the panel discussions are a focus on the state of AI in drug discovery and the future of digital medicines. A startup pitch contest spotlights companies seeking to improve clinical trials. Register for free today!
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The Pitch Perfect contest at MedCity INVEST PharmaTech, the free virtual conference scheduled for July 26, will spotlight five startups seeking to improve clinical trials.
At the MedCity INVEST PharmaTech virtual conference July 26, strategies and alignment between digital and pharma companies will be a major theme of the conference. Register now to join the conversation.
The MedCity INVEST PhrmaTech virtual conference, scheduled for Tuesday, July 26, offers free registration and a compelling day of conversations exploring the convergence of the health tech and biopharma sectors.
The Series E round, which was led by existing investors General Catalyst and Kinnevik, included participation from Merck Global Health Innovation Fund, Microsoft Ventures and others.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Prognos, a New York City-based artificial intelligence company, has wrapped up a $20.5 million Series C financing round from investors such as Cigna, Merck Global Health Innovation Fund, Hermed, Hikma Ventures, GIS Strategic Ventures, Maywic and Safeguard Scientifics.
Menlo Park, California-based HighBar Partners led the round. Psilos Group, TPG, Camden Partners and Merck Global Health Innovation Fund also participated.
Ayogo, a Vancouver-based digital health company, has raised $2.5 million in a Series A round to boost sales and marketing for a gaming platform to encourage people with chronic conditions to stay on their care plans. The funding came from a syndicate of investors consisting of Merck Global Health Innovations along with Excel Venture Management and […]
Identity management software company Exostar has received a $5 million investment from Merck’s venture arm to expand its healthcare and life sciences business. This centers on secure data collaboration, because big pharma – as pretty much every healthcare-related operation -needs to operate more lithely in the new world of big data. Data security’s become hugely paramount in the health […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
In the run-up to WellDoc’s commercial launch of its mobile health prescription app for Type 2 diabetes, it has focused exclusively on angel investors for fundraising. In a shift from that strategy, it has attracted investment from two institutional investors in a $20 million strategic financing deal, according to a company statement. It tapped Merck’s […]